EG24589A - Carrier with solid fibrinogen and solid thrombin - Google Patents

Carrier with solid fibrinogen and solid thrombin

Info

Publication number
EG24589A
EG24589A EG20020095A EG20020095A EG24589A EG 24589 A EG24589 A EG 24589A EG 20020095 A EG20020095 A EG 20020095A EG 20020095 A EG20020095 A EG 20020095A EG 24589 A EG24589 A EG 24589A
Authority
EG
Egypt
Prior art keywords
solid
carrier
thrombin
fibrinogen
solid fibrinogen
Prior art date
Application number
EG20020095A
Other languages
English (en)
Inventor
Dagmar Stimmeder
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Application granted granted Critical
Publication of EG24589A publication Critical patent/EG24589A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/36—Surgical swabs, e.g. for absorbency or packing body cavities during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/044—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/046—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00—Macromolecular products derived from proteins
    • C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00463—Plasters use haemostatic
    • A61F2013/00472—Plasters use haemostatic with chemical means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Medicinal Preparation (AREA)
EG20020095A 2001-01-25 2002-01-26 Carrier with solid fibrinogen and solid thrombin EG24589A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100135 2001-01-25
DKPA200100235 2001-02-13

Publications (1)

Publication Number Publication Date
EG24589A true EG24589A (en) 2009-12-01

Family

ID=26068956

Family Applications (2)

Application Number Title Priority Date Filing Date
EG2002010097A EG26417A (en) 2001-01-25 2002-01-26 A method for preparing collagen sponges has improved physical properties to heal and block wounds
EG20020095A EG24589A (en) 2001-01-25 2002-01-26 Carrier with solid fibrinogen and solid thrombin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EG2002010097A EG26417A (en) 2001-01-25 2002-01-26 A method for preparing collagen sponges has improved physical properties to heal and block wounds

Country Status (37)

Country Link
EP (4) EP1547626A3 (es)
JP (4) JP4535678B2 (es)
KR (2) KR100847417B1 (es)
CN (3) CN1264578C (es)
AR (3) AR032517A1 (es)
AT (2) ATE310044T1 (es)
AU (3) AU2002307809B2 (es)
BG (3) BG66343B1 (es)
BR (3) BRPI0206705B8 (es)
CA (3) CA2435159C (es)
CL (1) CL2015003111A1 (es)
CR (1) CR7034A (es)
CZ (3) CZ305120B6 (es)
DE (2) DE60203364T2 (es)
DK (2) DK1343542T3 (es)
EA (4) EA006540B1 (es)
EE (3) EE05678B1 (es)
EG (2) EG26417A (es)
ES (2) ES2238569T3 (es)
HK (2) HK1058319A1 (es)
HR (1) HRP20030648B1 (es)
HU (3) HUP0400768A3 (es)
IL (6) IL157096A0 (es)
IS (1) IS6885A (es)
ME (1) ME00587B (es)
MX (3) MXPA03006687A (es)
NO (3) NO20033297L (es)
NZ (3) NZ527167A (es)
PL (3) PL206197B1 (es)
PT (1) PT1343542E (es)
RS (1) RS50866B (es)
SI (2) SI1368419T1 (es)
SK (3) SK287874B6 (es)
TW (2) TWI255726B (es)
UA (1) UA73028C2 (es)
UY (1) UY27136A1 (es)
WO (3) WO2002058750A2 (es)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131933A1 (en) * 1996-01-16 2002-09-19 Yves Delmotte Biopolymer membrane and methods for its preparation
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7252837B2 (en) 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
CA2504706A1 (en) * 2002-11-04 2004-05-21 Nycomed Danmark Aps Coating of a particulate material with an organic solvent-based coating composition
CA2513319C (en) * 2003-01-20 2013-03-19 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Hemostatic material comprising thrombin, fibrinogen and bioabsorbable synthetic nonwoven fabric
DE602004025217D1 (es) 2003-04-04 2010-03-11 Tissuemed Ltd
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US7186684B2 (en) 2003-08-07 2007-03-06 Ethicon, Inc. Hemostatic device containing a protein precipitate
US8133504B2 (en) 2004-08-03 2012-03-13 Tissuemed Limited Tissue-adhesive materials
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
AU2005295367B2 (en) 2004-10-20 2010-12-02 Ethicon, Inc. A reinforced absorbable multilayered fabric for use in medical devices and method of manufacture
DK2052746T3 (en) * 2004-10-20 2014-12-08 Ethicon Inc Absorbable hemostatic patch
KR20060040329A (ko) * 2004-11-05 2006-05-10 나건 내시경을 통하여 도포 가능한 체내 지혈제 및 그 도포 방법
DK1879606T3 (da) 2005-04-25 2013-09-23 Massachusetts Inst Technology Selvorganiserende peptider til fremme af hæmostase
JP4864348B2 (ja) * 2005-05-27 2012-02-01 川澄化学工業株式会社 神経再生チューブ
CA2640629A1 (en) 2006-02-03 2007-08-09 Tissuemed Limited Tissue-adhesive materials
JP5671209B2 (ja) * 2006-02-14 2015-02-18 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション マトリックスタンパク質の光活性化架橋結合による組織の結合および／または密閉
ES2673947T3 (es) 2006-04-25 2018-06-26 Massachusetts Institute Of Technology Composiciones y métodos para afectar al movimiento de contaminantes, líquidos corporales u otras entidades y/o afectar a otras condiciones fisiológicas
CA2651941C (en) 2006-05-31 2015-02-17 Baxter International Inc. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
JP5965572B2 (ja) * 2006-08-04 2016-08-10 エスティービー リミテッド 創傷組織を治療するための固体包帯材
GB0623607D0 (en) * 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
CN101053679B (zh) * 2007-04-17 2010-05-26 浙江大学 一种纤维蛋白凝胶填充的聚合物多孔支架的制备方法
DE102007037056A1 (de) 2007-07-24 2009-01-29 Aesculap Ag Hämostyptikum
DE102007037053A1 (de) 2007-07-24 2009-01-29 Aesculap Ag Hämostyptikum für die minimal-invasive Operation
DE102007045066A1 (de) 2007-09-20 2009-04-02 Mike Ehrlich Material zur Blutstillung enthaltend synthetische Peptide oder Polysaccharide
DE102007000574A1 (de) 2007-10-25 2009-04-30 FILK Forschungsinstitut für Leder- und Kunstbahnen gGmbH Biologisch resorbierbares Schwammmaterial und Verfahren zu dessen Herstellung
JP2011500237A (ja) 2007-10-30 2011-01-06 バクスター・インターナショナル・インコーポレイテッド 内臓または体腔壁の欠陥を治療するための再生性の生体機能性コラーゲン生物基質の使用
CN101214391B (zh) * 2007-12-27 2010-05-19 广州倍绣生物技术有限公司 一种高效生物胶封闭剂及其应用
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
WO2010002435A2 (en) * 2008-07-03 2010-01-07 Kulinets Irina B Hemostatic pouch and method to stabilize hemostatic components
JPWO2010041636A1 (ja) 2008-10-06 2012-03-08 株式会社スリー・ディー・マトリックス 組織閉塞剤
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
PT2442835E (pt) 2009-06-16 2015-03-23 Baxter Healthcare Sa Esponja hemostática
US9271925B2 (en) 2013-03-11 2016-03-01 Bioinspire Technologies, Inc. Multi-layer biodegradable device having adjustable drug release profile
WO2011035020A1 (en) 2009-09-18 2011-03-24 Bioinspire Technologies, Inc. Free-standing biodegradable patch
US9439941B2 (en) 2009-12-14 2016-09-13 The University Of Hong Kong Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
US8771258B2 (en) 2009-12-16 2014-07-08 Baxter International Inc. Hemostatic sponge
AU2011210356B2 (en) * 2010-01-28 2015-05-28 Omrix Biopharmaceuticals Ltd. Method for improved fibrin sealing
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
WO2011151400A1 (en) 2010-06-01 2011-12-08 Baxter International Inc. Process for making dry and stable hemostatic compositions
CN103037847B (zh) 2010-06-01 2016-01-20 巴克斯特国际公司 用于制备干燥、稳定的止血组合物的方法
KR20130083393A (ko) 2010-06-01 2013-07-22 백스터 인터내셔널 인코포레이티드 건조 및 안정한 지혈 조성물의 제조 방법
CN103096944A (zh) * 2010-07-20 2013-05-08 一般财团法人化学及血清疗法研究所 组织粘合用片制剂
PT2713972T (pt) 2011-05-24 2017-09-22 Takeda As Transportador de colagénio enrolado
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
CN102357259A (zh) 2011-07-28 2012-02-22 王珊珊 一种生物蛋白海绵及其制备方法
US20130041406A1 (en) * 2011-08-10 2013-02-14 Brian W. Bear Surgical staple with localized adjunct coating
EP2556842A1 (en) 2011-08-11 2013-02-13 Bioftalmik, S.L. Composition in the form of film comprising fibrinogen and a fibrinogen activator and the applications thereof
US20130096063A1 (en) 2011-10-11 2013-04-18 Baxter Healthcare S.A. Hemostatic compositions
KR102135484B1 (ko) 2011-10-11 2020-07-20 백스터 인터내셔널 인코포레이티드 지혈 조성물
CN103889447B (zh) 2011-10-27 2015-11-25 巴克斯特国际公司 止血组合物
EP2822474B1 (en) 2012-03-06 2018-05-02 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
RU2669569C2 (ru) * 2012-05-14 2018-10-12 Тейдзин Лимитед Формованный пластинчатый продукт и гемостатический материал
WO2013174874A1 (en) 2012-05-24 2013-11-28 Takeda Nycomed As Apparatus and process for providing a coiled collagen carrier
PL2854737T3 (pl) * 2012-05-24 2017-04-28 Takeda As Opakowanie
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
AU2013286676B2 (en) 2012-07-06 2016-12-15 3-D Matrix, Ltd. Fill-finish process for peptide solutions
DE102013004420A1 (de) 2012-08-20 2014-02-20 Alexander Kopp Stützkörper und Verfahren zu seiner Herstellung
SG11201504347RA (en) * 2012-12-07 2015-07-30 Baxter Int Hemostatic foam
KR101401944B1 (ko) * 2012-12-11 2014-05-30 세원셀론텍(주) 콜라겐과 피브린이 혼합된 조직 실란트 및 그 제조방법
RU2700162C2 (ru) 2013-06-21 2019-09-13 Ферросан Медикал Дивайсиз А/С Расширенная под вакуумом сухая композиция и шприц для ее сохранения
US10765774B2 (en) * 2013-07-09 2020-09-08 Ethicon, Inc. Hemostatic pad assembly kit and method
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
CA2939696C (en) 2014-03-10 2023-01-10 3-D Matrix, Ltd. Self-assembling peptide compositions
JP6545727B2 (ja) 2014-03-10 2019-07-17 株式会社スリー・ディー・マトリックス 肺大気胞を治療するための自発組織化ペプチド
ES2927887T3 (es) 2014-03-10 2022-11-11 3 D Matrix Ltd Esterilización de composiciones peptídicas
JP6726852B2 (ja) 2014-10-13 2020-07-22 フェッローサン メディカル ディバイス エー／エス 止血および創傷治癒に使用するための乾燥組成物
AU2015371184B2 (en) 2014-12-24 2020-06-25 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
CN107771093B (zh) 2015-07-03 2021-06-15 弗罗桑医疗设备公司 用于混合两种组分和用于在存储条件下保持真空的注射器
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
CN106267328B (zh) * 2016-09-20 2019-04-12 安徽思维特生物科技有限公司 一种聚己内酯-胎牛皮胶原纤维复合止血凝胶的制备方法
CN106730031A (zh) * 2016-12-30 2017-05-31 清华大学 一种用于脊髓损伤修复的仿生纤维蛋白水凝胶束及其制备方法
JP2021506815A (ja) 2017-12-15 2021-02-22 株式会社スリー・ディー・マトリックス 界面活性ペプチドナノ構造および薬物送達における使用
EP3790600B1 (en) 2018-05-09 2023-12-27 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
RU2679616C1 (ru) * 2018-07-02 2019-02-12 Государственное бюджетное учреждение здравоохранения города Москвы Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского Департамента здравоохранения г. Москвы Способ приготовления тромбофибринового сгустка, обладающего ростстимулирующими свойствами
WO2020122007A1 (ja) * 2018-12-14 2020-06-18 株式会社ビーエムジー ２反応剤型のシート状組織接着補強材
CN112225937B (zh) * 2020-10-14 2022-11-01 中山大学 一种温敏型大孔生物水凝胶及其制备方法和应用
CN113117158B (zh) * 2021-03-10 2022-07-26 复旦大学 表面变性蛋白生物功能化修饰的材料及其制备方法和应用
CN114177346B (zh) * 2021-12-24 2023-05-26 中国人民解放军军事科学院军事医学研究院 一种止血组合物及止血贴与其应用
CN114246974B (zh) * 2021-12-24 2023-11-03 中国人民解放军军事科学院军事医学研究院 一种止血贴的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1596789A (es) * 1968-11-27 1970-06-22
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
BR8102435A (pt) * 1981-04-15 1982-11-30 Campos Vidal Benedicto Colageno i microfibrilar e microcristalino para aplicacao em medicina e farmacia
DE3214337C2 (de) * 1982-04-19 1984-04-26 Serapharm - Michael Stroetmann, 4400 Münster Resorbierbares Flachmaterial zum Abdichten und Heilen von Wunden und Verfahren zu dessen Herstellung
US4626286A (en) * 1983-10-31 1986-12-02 Schmid Laboratories, Inc. Collagen gel and the process of making said gel
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
FR2668936B1 (fr) * 1990-11-09 1993-01-15 Eberlin Jean Luc Greffon a base de collagene et de colle de fibrine pour la reconstruction osteo-cartilagineuse et son procede de preparation.
EP0578823B1 (en) * 1991-04-08 2002-01-23 Sumitomo Pharmaceuticals Company, Limited Porous solid preparation containing physiologically active protein substance
AT410754B (de) * 1993-03-31 2003-07-25 Nycomed Austria Gmbh Vorrichtung zum gleichmässigen auftragen einer suspension auf einen kollagenträger
US6177126B1 (en) * 1993-03-31 2001-01-23 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
JPH0759812A (ja) * 1993-08-27 1995-03-07 Koken Co Ltd 創傷カバ−材及びその製造方法
CA2198928A1 (en) * 1994-09-02 1996-03-14 Samar Nath Roy Production and secretion of recombinant fibrinogen by yeast
WO1997028832A1 (en) * 1996-02-06 1997-08-14 New Generation Medical Corporation Composition for sealing wounds
SK284693B6 (sk) * 1996-04-04 2005-09-08 Baxter Aktiengesellschaft Hemostatická huba, pokrytie rany, kit na prípravu pokrytia rany a spôsob prípravy huby
CA2330972C (en) * 1998-05-01 2008-08-19 Zymogenetics, Inc. Fully recombinant tissue sealant compositions
ATE254934T1 (de) * 1998-05-19 2003-12-15 American Nat Red Cross Blutstillende mehrschichtige bandage, die eine thrombinschicht zwischen zwei fibrinogenschichten enthält
EP1105051A4 (en) * 1998-08-10 2003-08-06 Fibrogen Inc HEMOSTATIC COMPOSITION BASED ON COLLAGEN I AND II FOR USE AS BLOCKING OF BLOOD TREATS AND AS WUNDAUFLAGE
KR100804434B1 (ko) * 1998-12-23 2008-02-20 체에스엘 베링 게엠베하 피브린계 접착제 과립 및 이의 제조방법
DE19922078A1 (de) * 1999-05-15 2000-11-23 Weitzel Kage Doris Gewebekonstrukt für die Transplantationschirurgie

Also Published As

Publication number Publication date
NO20033297D0 (no) 2003-07-22
RS50866B (sr) 2010-08-31
EP1359947A2 (en) 2003-11-12
PL206194B1 (pl) 2010-07-30
CN1487967A (zh) 2004-04-07
EA200300823A1 (ru) 2004-04-29
HUP0303896A2 (hu) 2004-03-01
ES2238569T3 (es) 2005-09-01
CL2015003111A1 (es) 2016-07-08
NZ527166A (en) 2005-03-24
WO2002070594A2 (en) 2002-09-12
SK10342003A3 (sk) 2004-02-03
PL363275A1 (en) 2004-11-15
NO20033295D0 (no) 2003-07-22
BRPI0206709B8 (pt) 2021-06-22
IL157095A (en) 2009-06-15
DE60207389D1 (de) 2005-12-22
EP1547626A2 (en) 2005-06-29
TWI237573B (en) 2005-08-11
BRPI0206709B1 (pt) 2015-09-08
EP1368419A2 (en) 2003-12-10
CA2434964A1 (en) 2002-08-01
AU2002255220B2 (en) 2007-05-31
BG66343B1 (bg) 2013-07-31
CA2435425A1 (en) 2002-08-01
EP1547626A3 (en) 2009-07-29
BR0206705A (pt) 2004-02-25
ATE291445T1 (de) 2005-04-15
YU67003A (sh) 2006-05-25
NO332462B1 (no) 2012-09-24
DK1343542T3 (da) 2005-07-25
WO2002058750A2 (en) 2002-08-01
CN1487843A (zh) 2004-04-07
AR032800A1 (es) 2003-11-26
BRPI0206705B8 (pt) 2021-07-27
DE60203364T2 (de) 2005-09-01
NZ527167A (en) 2005-02-25
TWI255726B (en) 2006-06-01
EA200300821A1 (ru) 2004-04-29
HRP20030648B1 (en) 2011-10-31
HU227987B1 (hu) 2012-07-30
NO20033295L (no) 2003-09-25
WO2002058749A2 (en) 2002-08-01
HUP0303893A2 (hu) 2004-03-01
KR100847417B1 (ko) 2008-07-18
NZ527165A (en) 2005-02-25
EE200300341A (et) 2003-10-15
SK288120B6 (sk) 2013-09-03
NO327386B1 (no) 2009-06-22
BG108121A (bg) 2004-08-31
CN1246047C (zh) 2006-03-22
HK1058371A1 (en) 2004-05-14
IL157096A (en) 2007-08-19
JP4535678B2 (ja) 2010-09-01
WO2002058749A3 (en) 2002-10-10
AR032517A1 (es) 2003-11-12
EE05685B1 (et) 2013-12-16
PT1343542E (pt) 2005-08-31
AR032400A1 (es) 2003-11-05
MXPA03006689A (es) 2004-03-12
EE200300349A (et) 2003-10-15
CA2434964C (en) 2009-04-21
PL205181B1 (pl) 2010-03-31
ATE310044T1 (de) 2005-12-15
WO2002058750A3 (en) 2002-10-31
HRP20030648A2 (en) 2005-06-30
JP2004520124A (ja) 2004-07-08
EA005697B1 (ru) 2005-04-28
EG26417A (en) 2013-10-22
EP1368419B1 (en) 2005-11-16
AU2002249528B2 (en) 2007-03-29
IL157097A (en) 2009-12-24
CZ20032199A3 (cs) 2003-12-17
CZ20032198A3 (cs) 2003-12-17
CN1507358A (zh) 2004-06-23
BRPI0206708B8 (pt) 2021-06-22
EA006686B1 (ru) 2006-02-24
SI1343542T1 (en) 2005-10-31
BR0206708A (pt) 2004-02-25
BRPI0206708B1 (pt) 2015-07-14
EA006540B1 (ru) 2006-02-24
IL157097A0 (en) 2004-02-08
BG66439B1 (bg) 2014-08-29
CZ305120B6 (cs) 2015-05-13
JP4104462B2 (ja) 2008-06-18
KR100830294B1 (ko) 2008-05-16
BG66420B1 (bg) 2014-03-31
EA200300822A1 (ru) 2004-02-26
JP2004521115A (ja) 2004-07-15
EA200401463A1 (ru) 2005-08-25
EE200300348A (et) 2003-10-15
CN1264578C (zh) 2006-07-19
DE60207389T2 (de) 2006-08-03
WO2002058749A8 (en) 2004-03-11
WO2002058750A8 (en) 2004-03-11
CA2435159A1 (en) 2002-09-12
BR0206709A (pt) 2004-02-17
EP1343542B1 (en) 2005-03-23
NO20033297L (no) 2003-09-25
CA2435159C (en) 2009-07-28
HUP0400768A2 (hu) 2004-07-28
SK10362003A3 (sk) 2004-03-02
BR0206705B1 (pt) 2012-08-07
EP1343542A2 (en) 2003-09-17
UA73028C2 (uk) 2005-05-16
IL157096A0 (en) 2004-02-08
PL366932A1 (en) 2005-02-07
HU228810B1 (hu) 2013-05-28
CZ20032197A3 (cs) 2003-11-12
CR7034A (es) 2004-03-05
HUP0303896A3 (en) 2005-12-28
IL157095A0 (en) 2004-02-08
KR20030086254A (ko) 2003-11-07
EE05587B1 (et) 2012-10-15
IS6885A (is) 2003-07-24
UY27136A1 (es) 2002-09-30
PL206197B1 (pl) 2010-07-30
SI1368419T1 (sl) 2006-06-30
PL363274A1 (en) 2004-11-15
WO2002070594A8 (en) 2004-03-11
SK287874B6 (sk) 2012-02-03
NO20033296D0 (no) 2003-07-22
NO20033296L (no) 2003-09-25
WO2002070594A3 (en) 2003-01-03
JP2007190399A (ja) 2007-08-02
AU2002307809B2 (en) 2007-10-04
ME00587A (en) 2011-12-20
ME00587B (me) 2011-12-20
MXPA03006687A (es) 2004-03-12
BG108122A (bg) 2004-09-30
DK1368419T3 (da) 2006-04-03
HUP0303893A3 (en) 2012-02-28
CN1290907C (zh) 2006-12-20
DE60203364D1 (de) 2005-04-28
KR20030085522A (ko) 2003-11-05
BG108123A (bg) 2004-09-30
CZ304357B6 (cs) 2014-03-26
MXPA03006688A (es) 2004-03-12
CA2435425C (en) 2010-07-27
JP2005502733A (ja) 2005-01-27
SK10352003A3 (sk) 2004-02-03
EA006700B1 (ru) 2006-02-24
HUP0400768A3 (en) 2006-01-30
HK1058319A1 (en) 2004-05-14
ES2253523T3 (es) 2006-06-01
EE05678B1 (et) 2013-10-15

Similar Documents

Publication Publication Date Title
EG24589A (en) Carrier with solid fibrinogen and solid thrombin
EP1519737A4 (en) FIBRIN NANOPARTICLES AND ITS USE
DE60317493D1 (en) Trizyklische thrombin rezeptor antagonisten
EP1463742A4 (en) NEW PYRAZOLO AND PYRROLO PYRIMIDINES AND THEIR USES
ZA200207650B (en) Absorbent structure and absorbent articles containing the absorbent structure.
EP1124822A4 (en) THROMBIN INHIBITORS
EP1408978A4 (en) NOVEL PHENYLAMINO-PYRIMIDINES AND THEIR USE
EP1312379A4 (en) FIBRINOGENIC REDUCTION AGENTS
IL154553A0 (en) Urocortin-iii and uses thereof
PL368975A1 (en) Absorbent article with improved fit
IL161261A0 (en) Storage-stable fibrinogen solutions
GB2379739B (en) Laboratory mounting, storage and prcessing members
PL370272A1 (en) Absorbent structure, and absorbent article containing the absorbent structure
EP1408985A4 (en) NEW PYRIDOPYRIMIDONE AND ITS USES
DE60239325D1 (en) Überexpression von phosphoenolpyruvat-carboxylase
GB0219764D0 (en) Load carrier
GB0102717D0 (en) Cells and uses therefor
EP1189618A4 (en) thrombin
AU2002356624A8 (en) Ptp10d, tec and edtp involved in triglycerid-metabolism
EP1437791A4 (en) SWITCH AND ITS APPLICATION
AU2003228397A8 (en) Hausp-p53 interaction and uses thereof
GB0105343D0 (en) Component carrier
PL368974A1 (en) Absorbent article with improved fit
GB0117453D0 (en) Carrier
AU2002316755A1 (en) Fibrinogen bandages and methods